Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Assort Health Raises $120 Million Series C to Scale Largest Deployment of AI Agents for the Patient Journey
Assort Health, the most widely used AI agents platform for the patient journey, today announced a $120 million Series C led by Menlo Ventures at a valuation of $1.2 billion. Assort has now raised more than $222 million to become the standard for healthcare organizations wanting to transform the patient journey with AI.
Healthcare providers now spend nearly twice as much on administration as on direct patient care. That $1.1 trillion in annual administrative burden, from scheduling calls to intake forms to referral loops, is one of the most consequential and correctable failures in modern healthcare. Assort was founded on a simple, uncomfortable conviction: the industry would never fix this problem from the middle. You had to start at the front door.
What began as the first voice AI agent to schedule a specialty appointment is now a platform spanning scheduling, intake forms, referrals, document processing, medication refills, real-time eligibility, lab requests, and payments. That expansion has been powered by more than 190 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, creating the largest proprietary specialty dataset in healthcare.
Synapse, Assort’s proprietary AI model, learns the patterns of specialty workflows across every deployment, then generates the edge cases, tests, and simulations each one has to handle. Even the most complex, provider-specific workflows go live with high automation and resolution rates. That advantage compounds with scale. In the last 15 months, revenue has grown 20x.
“After investing in Anthropic, our thesis was simple: find the best application-layer companies in every category,” said Matt Murphy, Partner at Menlo Ventures…
Full release here, originally announced June 24th, 2026.
Telepatia Raises $33 Million Series A
Brazil-Based Telepatia Raised $33 Million in Series A Funding Led by Andreessen Horowitz
Telepatia, a São Paulo, Brazil-based healthtech startup that provides an AI-native clinical platform, has raised a $33 million in Series A funding.
Investors
The round was led by Andreessen Horowitz and included participation from Palantir CTO Shyam Sankar, Rappi founder Simón Borrero, and Nubank founder David Vélez.
Telepatia Use of Funds
The funding will be used to scale Telepatia’s AI-powered healthcare platform, expand deployments across Latin America, and further develop its suite of AI healthcare employees, including AI doctors, nurses, and auditors…
Full release here, originally announced June 19th, 2026.
No comments:
Post a Comment